Tacrolimus Ointment
Product Images NDC 21922-011

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 21922-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Encube Ethicals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100g-carton (100g Carton)

100g-carton (100g   Carton)
Packaging label for Tacrolimus Ointment 0.1% by Encube Ethicals, Inc. The carton displays the product name with strength, dosage form (ointment), and the 100 g package size. It includes manufacturer information for Encube Ethicals Pvt. Ltd., and distributor details for Encube Ethicals, Inc. The label states the product is for dermatologic use only and is Rx only.*
FDA Label Image

100g-label (100g Label)

100g-label (100g   Label)
Tacrolimus Ointment 0.1% topical ointment label from Encube Ethicals, Inc. The label states it is for dermatologic use only, not for ophthalmic use, and the package contains 100 g. It includes dosage and storage instructions, manufacturer and distributor information, and a barcode with the NDC 21922-011-09.*
FDA Label Image

30g-carton (30g Carton)

30g-carton (30g   Carton)
Packaging label for Tacrolimus Ointment 0.1%, a topical ointment containing 1 mg/g tacrolimus. The label shows a 30 g carton distributed by Encube Ethicals, Inc. It includes usage instructions for dermatologic use only, and warnings such as dispensing the accompanying medication guide and not for ophthalmic use. The label also features the Encube logo and a barcode.*
FDA Label Image

30g-label (30g Label)

30g-label (30g   Label)
Packaging label for Tacrolimus Ointment 0.1%, a topical prescription ointment containing 1 mg/g tacrolimus. The 30 g label includes instructions for dermatologic use only, dosage guidance, storage conditions, manufacturer Encube Ethicals Pvt. Ltd. (India), and distributor Encube Ethicals, Inc. (USA). It features a prominently displayed brand name, strength, and Rx only indication.*
FDA Label Image

60g-carton (60g Carton)

60g-carton (60g   Carton)
Packaging label for Tacrolimus Ointment 0.1%, a topical ointment containing 1 mg/g tacrolimus. The box indicates a 60 g package and is labeled for dermatologic use only, not for ophthalmic use. Manufactured by Encube Ethicals Pvt. Ltd. and distributed by Encube Ethicals, Inc. The label features dosing, storage, and warning instructions alongside manufacturer and barcode details.*
FDA Label Image

60g-label (60g Label)

60g-label (60g   Label)
Tacrolimus Ointment 0.1% topical ointment label by Encube Ethicals, Inc. The label states it is for dermatologic use only, not for ophthalmic use, in a 60 g package. It includes storage instructions, a warning to keep out of reach of children, and manufacturer/distributor information for Encube Ethicals Pvt. Ltd. and Encube Ethicals, Inc.*
FDA Label Image

Fig-02 (Fig 02)

Fig-02 (Fig 02)
A line graph showing the percentage of body surface area affected over a 12-week period. The graph compares two treatments: Vehicle and 0.03%, with data points marked by closed and open circles, respectively, including error bars representing 95% confidence intervals.*
FDA Label Image

Fig-03 (Fig 03)

Fig-03 (Fig 03)
A line graph depicting mean erythema scores over 12 weeks for three groups: Vehicle, Tacrolimus Ointment 0.03%, and Tacrolimus Ointment 0.1%. The y-axis shows mean erythema score with 95% confidence intervals, while the x-axis represents time in weeks. The graph shows a decrease in scores over time for both Tacrolimus groups compared to the Vehicle.*
FDA Label Image

Fig-04 (Fig 04)

Fig-04 (Fig 04)
A line graph depicting mean erythema score (mean ± 95% confidence interval) over a 12-week period. The graph compares two groups: one labeled 'Vehicle' with consistently higher scores, and the other labeled '0.03%' showing a decreasing trend in erythema score over time. The x-axis represents time in weeks, and the y-axis represents mean erythema score ranging from 0 to 2.*
FDA Label Image

Fig-01 (Fig 1)

Fig-01 (Fig 1)
A line graph showing percentage of body surface area affected over 12 weeks. The x-axis represents time in weeks, and the y-axis shows the percent body surface area affected with mean and 95% confidence interval. Three data series labeled: Vehicle, 0.03%, and 0.1%, showing change trends over time.*
FDA Label Image

Structute Tacrolimus (Structure Tacro)

Structute Tacrolimus (Structure Tacro)
Chemical structure of tacrolimus, the active ingredient in Tacrolimus Ointment 0.1%. The diagram shows the detailed molecular arrangement including atom connections and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.